Role of USP35 in the Detection of Ferroptosis in Juvenile Autoimmune Hepatitis

NCT06896383 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2025-03-26

No results posted yet for this study

Summary

1. To evaluate the immunohistochemical expression of USP35 in cases of juvenile autoimmune hepatitis and control cases.
2. To correlate this with the level of necro-inflammation and extent of fibrosis using Massion's trichrome stain in cases of juvenile autoimmune hepatitis.

Conditions

  • Autoimmune Hepatitis

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Howadya Ismail Hassan El Sayed, PhD · Assiut University

  • Moemen Mostafa Ahmed Hafez, PhD · Assiut University

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-11-30
Primary Completion
2026-11-30
Completion
2027-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06896383 on ClinicalTrials.gov